Stay updated on Nivolumab for Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab for Esophageal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated to v3.4.2. The funding-status notice from the previous version (v3.4.1) has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding-lapse notice and a new revision tag (v3.4.1) were added. The old revision tag (v3.4.0) was removed.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a Show glossary option and updated labels for QC metadata (Last Update Submitted that Met QC Criteria) and No FEAR Act Data, along with a new revision note (Revision: v3.4.0) replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor version update visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Locations section shows new recruitment sites across multiple regions and removal of some prior sites. Revision updated to v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed, indicating a site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab for Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Esophageal Cancer Clinical Trial page.